A Novel Immunomodulator, FTY-720 Reverses Existing Cardiac Hypertrophy and Fibrosis From Pressure Overload by Targeting NFAT (Nuclear Factor of Activated T-cells) Signaling and Periostin

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Circulation: Heart Failure

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCHEARTFAILURE.112.000123PMID 23753531PMCID PMC3871200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-β pathway

  2012cited by this paper
• Reverse remodeling in heart failure—mechanisms and therapeutic opportunities

  2012cited by this paper
• Animal models of heart failure: a scientific statement from the American Heart Association.

  2012cited by this paper
• Deprivation of MKK7 in cardiomyocytes provokes heart failure in mice when exposed to pressure overload.

  2011cited by this paper
• Pak1 as a Novel Therapeutic Target for Antihypertrophic Treatment in the Heart

  2011cited by this paper
• Contemporary Reviews in Cardiovascular Medicine The Progression of Hypertensive Heart Disease

  2011cited by this paper
• Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.

  2010cited by this paper
• Roles of epithelial cell-derived periostin in TGF-β activation, collagen production, and collagen gel elasticity in asthma

  2010cited by this paper
• Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents.

  2010cited by this paper
• Targeted Deletion of the Extracellular Signal-Regulated Protein Kinase 5 Attenuates Hypertrophic Response and Promotes Pressure Overload–Induced Apoptosis in the Heart

  2010cited by this paper
• Targeting sphingosine-1-phosphate signalling for cardioprotection.

  2009cited by this paper
• Tissue stiffness, latent TGF-β1 Activation, and mechanical signal transduction: Implications for the pathogenesis and treatment of fibrosis

  2009cited by this paper
• Cardiac-Specific Deletion of Mkk4 Reveals Its Role in Pathological Hypertrophic Remodeling but Not in Physiological Cardiac Growth

  2009cited by this paper
• Origin of Cardiac Fibroblasts and the Role of Periostin

  2009cited by this paper
• Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis.

  2009cited by this paper
• Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system.

  2008cited by this paper
• Periostin as a Heterofunctional Regulator of Cardiac Development and Disease

  2008cited by this paper
• Selective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate.

  2008influential reference
• Periostin Is Required for Maturation and Extracellular Matrix Stabilization of Noncardiomyocyte Lineages of the Heart

  2008cited by this paper
• Genetic Manipulation of Periostin Expression in the Heart Does Not Affect Myocyte Content, Cell Cycle Activity, or Cardiac Repair

  2008cited by this paper
• Genetic Manipulation of Periostin Expression Reveals a Role in Cardiac Hypertrophy and Ventricular Remodeling

  2007cited by this paper
• TGFbeta, cardiac fibroblasts, and the fibrotic response.

  2007cited by this paper
• ECM remodeling in hypertensive heart disease.

  2007cited by this paper
• Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface

  2007cited by this paper
• Cardiac GPCRs: GPCR signaling in healthy and failing hearts.

  2007cited by this paper
• FTY720, a Synthetic Sphingosine 1 Phosphate Analogue, Inhibits Development of Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice

  2007cited by this paper
• TGFβ, cardiac fibroblasts, and the fibrotic response

  2007cited by this paper
• FTY720: Placebo‐Controlled Study of the Effect on Cardiac Rate and Rhythm in Healthy Subjects

  2006cited by this paper
• FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.

  2005cited by this paper
• Hypertrophy of the heart: a new therapeutic target?

  2004cited by this paper
• Novel Functional Interaction between the Plasma Membrane Ca2+ Pump 4b and the Proapoptotic Tumor Suppressor Ras-associated Factor 1 (RASSF1)*

  2004cited by this paper
• FTY720: mechanism of action and potential benefit in organ transplantation.

  2004cited by this paper
• Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

  2004cited by this paper
• FTY720: from bench to bedside.

  2004cited by this paper
• A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

  2003cited by this paper
• Statistical significance for genomewide studies

  2003cited by this paper
• Cardiac hypertrophy: the good, the bad, and the ugly.

  2003cited by this paper
• Cardiac Fibrosis as a Cause of Diastolic Dysfunction

  2002influential reference
• FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity.

  2002influential reference
• The Role of Interleukin-6 in the Failing Heart

  2001cited by this paper
• G-proteins in growth and apoptosis: lessons from the heart

  2001cited by this paper
• Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• TGF-beta signal transduction.

  1998cited by this paper
• An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.

  1994cited by this paper
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method

  year unknowncited by this paper

• Cardiomyocyte S1PR1 promotes cardiac regeneration via AKT/mTORC1 signaling pathway

  2025cites this paper
• Angiotensin II Promotes Progressive Activation of Fibrogenic Periostin-Lineage Cells in Lung and Kidney

  2025cites this paper
• Cardiomyocyte Rac1 signaling in hypertrophy, arrhythmia, and cardiac stress adaptation

  2025cites this paper
• Qishen Yiqi alleviates periostin-mediated cardiac fibrosis and hypertrophy in Dahl hypertensive rat hearts and angiotensin II-induced cardiac organoids

  2025cites this paper
• p21‐Activated Kinase 1 (Pak1) as an Element in Functional and Dysfunctional Interplay Among the Myocardium, Adipose Tissue, and Pancreatic Beta Cells

  2025influential citation
• Expression of the Pro-Fibrotic Marker Periostin in a Mouse Model of Duchenne Muscular Dystrophy

  2024cites this paper
• Application of Compounds with Anti‐Cardiac Fibrosis Activity: A Review

  2024cites this paper
• P21-activated kinase-1 signaling is required to preserve adipose tissue homeostasis and cardiac function

  2024cites this paper
• SPHK1/S1P/S1PR pathway promotes the progression of peritoneal fibrosis by mesothelial‐mesenchymal transition

  2024cites this paper
• Implications of S-glutathionylation of sarcomere proteins in cardiac disorders, therapies, and diagnosis

  2023cites this paper
• Searching for Effective Treatments in HFpEF: Implications for Modeling the Disease in Rodents

  2023cites this paper
• Restored autophagy is protective against PAK3-induced cardiac dysfunction

  2023cites this paper
• Sphingosine-1-phosphate levels are inversely associated with left ventricular and atrial chamber volume and cardiac mass in men

  2023cites this paper
• Serum Periostin May Help to Identify Patients with Poor Collaterals in the Hyperacute Phase of Ischemic Stroke

  2022cites this paper
• The P21-Activated Kinase 1 and 2 As Potential Therapeutic Targets for the Management of Cardiovascular Disease.

  2022cites this paper
• Simvastatin attenuates the c-Raf/Erk and calcineurin-NFATc2 pathways via inhibition of Hsp90 activity during the development of heart failure.

  2022cites this paper
• Sphingosine-1-phosphate and Sphingosine-1-phosphate receptors in the cardiovascular system: pharmacology and clinical implications.

  2022cites this paper
• The antithetic role of ceramide and sphingosine‐1‐phosphate in cardiac dysfunction

  2021cites this paper
• SCIEN OPEN Silencing miR-370-3p rescues funny current and sinus node function in heart failure

  2021cites this paper
• Resveratrol against Cardiac Fibrosis: Research Progress in Experimental Animal Models

  2021cites this paper
• Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β.

  2021cites this paper
• Dihydrosphingosine driven enrichment of sphingolipids attenuates TGFβ induced collagen synthesis in cardiac fibroblasts

  2021cites this paper
• Hsp90 Inhibitor Attenuates the Development of Pathophysiological Cardiac Fibrosis in Mouse Hypertrophy via Suppression of the Calcineurin-NFAT and c-Raf-Erk Pathways

  2021cites this paper
• Deletion of P21-activated kinase-1 induces age-dependent increased visceral adiposity and cardiac dysfunction in female mice

  2021cites this paper
• Silencing miR-370-3p rescues funny current and sinus node function in heart failure

  2020cites this paper
• Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart

  2020cites this paper
• Role of sphingosine 1-phosphate signalling in tissue fibrosis.

  2020cites this paper
• Roles of BATF/JUN/IRF4 complex in tacrolimus mediated immunosuppression on Tfh cells in acute rejection after liver transplantation

  2020cites this paper
• Sphingolipids in the Heart: From Cradle to Grave

  2020cites this paper
• Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology.

  2020cites this paper
• Sphingolipid Mediators of Myocardial Pathology

  2019cites this paper
• The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis

  2019cites this paper
• Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy.

  2019cites this paper
• Severe murine limb‐girdle muscular dystrophy type 2C pathology is diminished by FTY720 treatment

  2017cites this paper
• Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy

  2017cites this paper
• Sphingosine-1-phosphate ameliorates the cardiac hypertrophic response through inhibiting the activity of histone deacetylase-2.

  2017cites this paper
• Matrine attenuates cardiac fibrosis by affecting ATF6 signaling pathway in diabetic cardiomyopathy

  2017cites this paper
• Calcium‐dependent Nedd4‐2 upregulation mediates degradation of the cardiac sodium channel Nav1.5: implications for heart failure

  2017cites this paper
• The p21‐activated kinase 1 (Pak1) signalling pathway in cardiac disease: from mechanistic study to therapeutic exploration

  2017cites this paper
• FTY720 Supplementation Partially Improves Erectile Dysfunction in Rats With Streptozotocin-Induced Type 1 Diabetes Through Inhibition of Endothelial Dysfunction and Corporal Fibrosis.

  2017cites this paper
• Expression profile of matricellular proteins in hypertrophied right ventricle of monocrotaline-induced pulmonary hypertensive rats

  2017cites this paper
• Rescue of Pressure Overload‐Induced Heart Failure by Estrogen Therapy

  2016cites this paper
• Store-Operated Ca2+ Entry (SOCE) contributes to angiotensin II-induced cardiac fibrosis in cardiac fibroblasts.

  2016cites this paper
• Adoptive transfer of FTY720-treated immature bone marrow-derived dendritic cells (BMDCs) significantly reduced the spontaneous resorption rate in the CBA/J × DBA/2 mouse model

  2016cites this paper
• Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice

  2016cites this paper
• Periostin expression induced by oxidative stress contributes to myocardial fibrosis in a rat model of high salt-induced hypertension

  2016cites this paper
• Roles and regulation of protein phosphatase 2A (PP2A) in the heart.

  2016cites this paper
• FTY720 (Gilenya) treatment prevents spontaneous autoimmune myocarditis and dilated cardiomyopathy in transgenic HLA-DQ8-BALB/c mice.

  2016cites this paper
• Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists Cause Differential Cardiac Gene Expression in Pressure Overload-induced Cardiac Hypertrophy

  2016cites this paper
• Implication of sphingosin-1-phosphate in cardiovascular regulation.

  2016cites this paper
• Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary Atherosclerosis

  2016cites this paper
• Smad3 Couples Pak1 With the Antihypertrophic Pathway Through the E3 Ubiquitin Ligase, Fbxo32

  2015cites this paper
• MyoD transcription factor induces myogenesis by inhibiting Twist-1 through miR-206

  2015cites this paper
• Immunomodulation by splenectomy or by FTY720 protects the heart against ischemia reperfusion injury

  2015cites this paper
• Possible involvement of TGF-β/periostin in fibrosis of right atrial appendages in patients with atrial fibrillation.

  2015cites this paper
• Knockout of p21-activated kinase-1 attenuates exercise-induced cardiac remodelling through altered calcineurin signalling.

  2015cites this paper
• Novel insights into mechanisms for Pak1-mediated regulation of cardiac Ca2+ homeostasis

  2015cites this paper
• Regulation of Ca2+ transient by PP2A in normal and failing heart

  2015cites this paper
• Gene Expression in Experimental Aortic Coarctation and Repair: Candidate Genes for Therapeutic Intervention?

  2015cites this paper
• FTY720, a Sphingosine-1 Phosphate Receptor Modulator, Improves Liver Fibrosis in a Mouse Model by Impairing the Motility of Bone Marrow-Derived Mesenchymal Stem Cells

  2014cites this paper
• SLC41A1 knockdown inhibits angiotensin II-induced cardiac fibrosis by preventing Mg(2+) efflux and Ca(2+) signaling in cardiac fibroblasts.

  2014cites this paper
• Targeting cardiac hypertrophy: toward a causal heart failure therapy.

  2014cites this paper
• PAK1 is a novel cardiac protective signaling molecule

  2014cites this paper
• Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis

  2014cites this paper